Patient Care and Research

ASTRO Guideline on Definitive and Adjuvant Radiation Therapy in Non-small Cell Lung Cancer (NSCLC)

Published: June 2015 (Web posted May 2015)
Reaffirmed: 2017

Read Definitive Radiation Therapy Executive Summary
Read Adjuvant Radiation Therapy Executive Summary
Read Full-Text Guideline

This guideline addresses five key questions related to appropriate use of radiation therapy (RT) in the definitive and adjuvant settings for locally advanced non-small cell lung cancer (NSCLC). 1) the ideal radical RT dose fractionation for radiotherapy alone, and 2) for chemoradiation; 3) ideal timing of radical radiotherapy with systemic chemotherapy; 4) indications for postoperative adjuvant RT, and 5) preoperative neoadjuvant RT.

Endorsed by:

American Society of Clinical Oncology

Key Points:

  • Survival rates
  • Local-regional tumor control
  • Regional and distant failure rates
  • Treatment toxicity
  • Response rate

Resources:

Effectiveness of Radiofrequency Ablation with SBRT in Inoperable Stage I NSCLC (CME)
Patient Brochure
 

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.